October 21-23, 2024 | Rockville, Maryland
Registration is now open, with early bird pricing available until June 19. GRx+Biosims 2024 is the leading scientific, regulatory, and policy event for the U.S. generics and biosimilars industry. We are excited to announce that top officials and subject-matter experts, including Dr. Jacqueline Corrigan-Curray, Dr. Iilun Murphy, Dr. Sarah Yim, and Dr. Elizabeth Miller from FDA, will be sharing their knowledge and best practices. Join us for a special session reflecting on the remarkable career of Dr. Janet Woodcock, who recently retired from FDA. The GRx+Biosims learning tracks will feature timely discussions and insights relevant to technical, regulatory, and policy professionals. Gain insights to enhance your understanding of succeeding in generic and biosimilar development, regulatory processes and approvals, and the evolving policy landscape.
